BRIEF-Outlook Therapeutics Requests Type A Meeting With FDA

Reuters09-03

BRIEF-Outlook <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Requests Type A Meeting With FDA

Outlook Therapeutics Inc OTLK.O:

OUTLOOK THERAPEUTICS REQUESTS TYPE A MEETING WITH FDA
OUTLOOK THERAPEUTICS INC: TYPE A MEETING REQUEST HAS BEEN SUBMITTED TO U.S. FDA TO DISCUSS CRL REGARDING BLA RESUBMISSION FOR ONS-5010
OUTLOOK THERAPEUTICS: REQUESTED TYPE A MEETING SEEKS TO CLARIFY DETAILS OF CONFIRMATORY EVIDENCE REQUIRED BY FDA FOR ONS-5010

Source text: ID:nGNX9ZqXtQ

Further company coverage: OTLK.O

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2564812773?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-03 00:58","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2564812773","market":"us","top_or_hot":-1,"title":"BRIEF-Outlook Therapeutics Requests Type A Meeting With FDA","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Outlook <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Requests Type A Meeting With FDA</title></head><body><p>Outlook Therapeutics Inc <span>OTLK.O</span>:</p><ul><li><p>OUTLOOK THERAPEUTICS REQUESTS TYPE A MEETING WITH FDA</p></li><li><p>OUTLOOK THERAPEUTICS INC: TYPE A MEETING REQUEST HAS BEEN SUBMITTED TO U.S. FDA TO DISCUSS CRL REGARDING BLA RESUBMISSION FOR ONS-5010</p></li><li><p>OUTLOOK THERAPEUTICS: REQUESTED TYPE A MEETING SEEKS TO CLARIFY DETAILS OF CONFIRMATORY EVIDENCE REQUIRED BY FDA FOR ONS-5010</p></li></ul><p>Source text: <span>ID:nGNX9ZqXtQ</span></p><p>Further company coverage: <span>OTLK.O</span></p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Outlook Therapeutics Requests Type A Meeting With FDA</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Outlook Therapeutics Requests Type A Meeting With FDA\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-09-03 00:58</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Outlook <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Requests Type A Meeting With FDA</title></head><body><p>Outlook Therapeutics Inc <span>OTLK.O</span>:</p><ul><li><p>OUTLOOK THERAPEUTICS REQUESTS TYPE A MEETING WITH FDA</p></li><li><p>OUTLOOK THERAPEUTICS INC: TYPE A MEETING REQUEST HAS BEEN SUBMITTED TO U.S. FDA TO DISCUSS CRL REGARDING BLA RESUBMISSION FOR ONS-5010</p></li><li><p>OUTLOOK THERAPEUTICS: REQUESTED TYPE A MEETING SEEKS TO CLARIFY DETAILS OF CONFIRMATORY EVIDENCE REQUIRED BY FDA FOR ONS-5010</p></li></ul><p>Source text: <span>ID:nGNX9ZqXtQ</span></p><p>Further company coverage: <span>OTLK.O</span></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250902:nTUA3TCWBQ:1","article_id":"2564812773","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2564812773","pubTimestamp":1756832291,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Outlook Therapeutics Requests Type A Meeting With FDAOutlook Therapeutics Inc OTLK.O:OUTLOOK THERAPEUTICS REQUESTS TYPE A MEETING WITH FDAOUTLOOK THERAPEUTICS INC: TYPE A MEETING REQUEST HAS BEE","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","OTLK":"Outlook Therapeutics, Inc."},"translate_title":"BRIEF-Outlook Therapeutics请求与FDA举行A型会议","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OTLK":0.9},"content_text":"BRIEF-Outlook Therapeutics Requests Type A Meeting With FDAOutlook Therapeutics Inc OTLK.O:OUTLOOK THERAPEUTICS REQUESTS TYPE A MEETING WITH FDAOUTLOOK THERAPEUTICS INC: TYPE A MEETING REQUEST HAS BEEN SUBMITTED TO U.S. FDA TO DISCUSS CRL REGARDING BLA RESUBMISSION FOR ONS-5010OUTLOOK THERAPEUTICS: REQUESTED TYPE A MEETING SEEKS TO CLARIFY DETAILS OF CONFIRMATORY EVIDENCE REQUIRED BY FDA FOR ONS-5010Source text: ID:nGNX9ZqXtQFurther company coverage: OTLK.O","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"policyRegulatory","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2564812773","isCrawlerRequest":true}